Atticus Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05K | Buy |
+2
| New | +$1.05K | ﹤0.01% | 598 |
|
|
2023
Q1 | – | Sell |
-3
| Closed | -$2.16K | – | 577 |
|
|
2022
Q4 | $2.16K | Sell |
3
-6
| -67% | -$4.33K | ﹤0.01% | 460 |
|
|
2022
Q3 | $5K | Hold |
9
| – | – | ﹤0.01% | 439 |
|
|
2022
Q2 | $5K | Hold |
9
| – | – | ﹤0.01% | 471 |
|
|
2022
Q1 | $6K | Buy |
9
+4
| +80% | +$2.67K | ﹤0.01% | 453 |
|
|
2021
Q4 | $3K | Sell |
5
-61
| -92% | -$36.6K | ﹤0.01% | 406 |
|
|
2021
Q3 | $40K | Sell |
66
-2
| -3% | -$1.21K | 0.02% | 260 |
|
|
2021
Q2 | $38K | Hold |
68
| – | – | 0.02% | 251 |
|
|
2021
Q1 | $32K | Sell |
68
-58
| -46% | -$27.3K | 0.02% | 242 |
|
|
2020
Q4 | $61K | Hold |
126
| – | – | 0.03% | 192 |
|
|
2020
Q3 | $71K | Hold |
126
| – | – | 0.04% | 159 |
|
|
2020
Q2 | $79K | Buy |
126
+3
| +2% | +$1.88K | 0.05% | 144 |
|
|
2020
Q1 | $60K | Buy |
+123
| New | +$60K | 0.05% | 162 |
|